Retatrutide must be dosed very carefully, because the dose must be improved slowly to minimize Unwanted effects. An average starting dose for the 1st 4 months in phase 2 trials is 2mg/week. The gradual rise in dosage must last for at least 12 months. As a triple-receptor investigational therapy, https://andretmyfz.weblogco.com/38674845/retatrutide-dosing-chart-options